Apotex Fermentation Inc.

Apotex Fermentation Inc.

Apotex Fermentation Inc. is part of the Apotex Group of
Companies, the largest Canadian-owned pharmaceutical group. The
purpose of AFI is to discover and develop fermentation-based
technologies for the production of Active Pharmaceutical
Ingredients (APIs) and to manufacture APIs for eventual sale as
final dosage forms in Canada and internationally. AFI is an
advanced technology company utilizing state-of-the-art
techniques for search and discovery, strain selection and
improvement and bioprocess scale-up. AFI staff is highly
qualified and trained in sophisticated chemical biological and
pharmaceutical technologies. Our multimillion dollar facility
in Southwest Winnipeg is the largest fermentation-based GMP
facility in Canada.

Company Details

Year Established: 1991

Total Sales ($CDN): $1,000,000 - $5,000,000

Number of Employees: 150

Company Information

Sandy Fowler
Title: Controller
Area of Responsibility: Domestic Sales & Marketing, Export Sales & Marketing, Management Executive, Finance/Accounting, Customer Service, Government Relations, Administrative Services
Telephone: (204) 989-6830
Fax: (204) 488-0486
Email: Click Here

Products

Lovastatin

Cyclosporin
Bulk pharmaceutical product Cyclosporin USP

Pravastatin
Bulk pharmaceutical product Pravastatin USP

Contract Manufacturing
Contract manufacturing of active pharmaceutical ingredients using fermentation based technologies under GMP

Services

Research And Development Research and Development of fermentation based technologies in the pharmaceutical industry

Process Development Development of microbiological and chemical processes for the production of active pharmaceutical ingredients

Scale Up Scale up of lab scale microbiological and chemical processes to commercial production scale processes for the manufacture of active pharmaceutical